Protavio Ltd

Protavio presented at the 8th Network Meeting for Luminex Immune Assay Users. Our co-founder, Dr. Leonidas Alexopoulos, shared how Protavio implemented a GMP & ISO13485 system: a crucial component for translating multiplex biomarkers to clinical practice. eu1.hubs.ly/H0cHWKx0

Protavio will be attending the upcoming Olink Proteomics World virtual conference on Thursday September 26th. Come check out our work at the digital poster hall and discuss on its application for biomarker discovery in early cancer detection! eu1.hubs.ly/H0cBSMB0

O Λεωνίδας Αλεξόπουλος, Καθηγητής ΕΜΠ, παρουσίασε σε Συνεδρία της Συνόδου των Πρυτάνενων σε θέματα Καινοτομίας την ιστορία της Προτάβιο από την έρευνα στην παραγωγή. Η Ελλάδα μας αλλάζει και είμαστε χαρούμενοι που είμαστε μέρος αυτής της αλλαγής! eu1.hubs.ly/H0bwynF0

We are officially a certified service provider for Olink Explore! We achieved great results in our inter-laboratory comparison w/ Olink Uppsala: CV=12%, Pearson=0.98, R² =0.95. Learn more here eu1.hubs.ly/H0bgJF00 #Proteomics #BiomarkerDiscovery #OlinkExplore #Protavio

Last week, the #1st_Greek_Forum_on_Cancer, organized by Hellenic Cancer Federation | ELLOK, provided a holistic view of our battle with cancer discussing vital topics such as policy, screening, research, and funding strategies. eu1.hubs.ly/H0b6kl20

Protavio's latest GMP-produced batch of Luminex® Serological Assays for vaccine assessment and QC is ready for shipment. Read the full news release eu1.hubs.ly/H0b296x0! #Proteomics #GMP #Luminex #VaccineAssessment #Pharma #VaccineDevelopment

Protavio is thrilled to be participating as an exhibitor at the EPHAR2024 conference organized by The Federation of European Pharmacological Societies in Athens, Greece! eu1.hubs.ly/H09V1TM0 #EPHAR2024 #Proteomics #Biotech #BiomarkerDiscovery #AssayDevelopment #Protavio

Very happy to be featured at Forbes Greece for our pioneering work in early cancer detection! #proteomics #protavio #biomarkers #earlycancerdetection #Luminex #Olink

Just one week left to apply for our Project Manager role! We love to hear from you—apply now using this link: eu1.hubs.ly/H08VhPd0

Protavio took part in the Swiss Biotech Days 2024. A huge thank you to HBio for putting Greek biotech innovation in the spotlight. It was an absolute pleasure to reconnect with our valued partners at Luminex and to engage with new potential partners.

Protavio participated in @DIOPTRA-Project in the beautiful premises of Cambridge University showcasing our @Olink / @Luminex-powered proteomic biomarker discovery method to identify novel biomarkers for screening colorectal cancer. #biomarkerdiscovery #proteomics #olink #Luminex

Ο συνεργάτης μας, Καθηγητής Ιωάννης Παπανικολάου εμφανίστηκε στην εκπομή του OPEN και συζήτησε την από κοινού ανάπτυξη ενός νέου τεστ διάγνωσης καρκίνου του παχέος εντέρου μέσω της κοινοπραξίας του @dioptra_project eu1.hubs.ly/H08wsXc0

Protavio Ltd is seeking a driven and experienced Project Manager to join our team linkedin.com/jobs/view/3886…

We're excited to announce the latest addition to the Protavio family of xMAP instruments: the Luminex xMAP INTELLIFLEX DR-SE System. Stay tuned as we harness its potential for custom multiplex assays, advancing biomarker profiling and clinical impact. eu1.hubs.ly/H08pVH90

We are hiring! There are two new opportunities to work with us! The first opportunity is on Project Management and the other is open to anyone who possesses a **unique talent** that aligns with our vision. Click below and select any of the two positions. eu1.hubs.ly/H08mfWt0

Our GMP-produced 13-plex Pneumococcal IgG Serological Luminex Assay is ready for shipment! It measures IgG antibodies against 13 strains of Streptococcus pneumonia found in the Prevenar 13. Do you like our kit design? Learn more eu1.hubs.ly/H08kKWF0 #pneumoniae #pcv13

Protavio is at the forefront of colorectal cancer (CRC) screening through participation in the @dioptra_project aiming to discover a blood-based protein biomarker panel and develop a multiplex screening kit for early cancer and advanced adenoma detection. eu1.hubs.ly/H08h-Jh0

🎉Protavio Announces the Winner of the Proteomics Sample Testing Contest!🎉 We are excited to announce Maria Grigoriou, a Postdoc Fellow at the @BRFAA_IIBEAA under the supervision of Prof. Boumpas as the winner of our contest! Read more on our news post eu1.hubs.ly/H08dfQw0

Lung cancer is the leading cause of cancer death globally. The Global Cancer Observatory from IARC recently released new estimates: in Europe the cumulative risk for cancer incidence is 65% and for cancer mortality is almost half (28,5%). Lung cancer has the highest mortality.

We are thrilled to announce the integration of the Olink Explore platform into our service offerings! This marks a significant milestone in our mission to harness the power of proteomics for better health. Learn more by reading our latest blog post. eu1.hubs.ly/H07LxSL0